LeMaitre Vascular Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • LeMaitre Vascular's estimated annual revenue is currently $140.1M per year.(i)
  • LeMaitre Vascular's estimated revenue per employee is $251,000

Employee Data

  • LeMaitre Vascular has 558 Employees.(i)
  • LeMaitre Vascular grew their employee count by 8% last year.

LeMaitre Vascular's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
Sr VP Operations - ArtegraftReveal Email/Phone
3
VP, MarketingReveal Email/Phone
4
SVP, OperationsReveal Email/Phone
5
VP, Research and DevelopmentReveal Email/Phone
6
SVP Clinical, Regulatory and Quality AffairsReveal Email/Phone
7
VP, Information TechnologyReveal Email/Phone
8
VP, Business DevelopmentReveal Email/Phone
9
VP, EMEA OperationsReveal Email/Phone
10
ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is LeMaitre Vascular?

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.

keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

N/A

Total Funding

558

Number of Employees

$140.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LeMaitre Vascular News

2022-04-19 - LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of “Buy” from Brokerages. Posted by admin on Apr 25th, 2022.

2022-04-17 - LeMaitre Vascular (LMAT) Scheduled to Post Quarterly ...

Analysts expect LeMaitre Vascular to post earnings of $0.28 per share for the quarter. Persons that are interested in participating in the...

2022-03-30 - LeMaitre Vascular: Steady As She Goes

LeMaitre Vascular continues to be a solid secular growth play in the vascular business. · The company has seen continuation of strong organic...

2021-07-14 - LeMaitre Announces Pricing of Public Offering of Common Stock

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.5 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$179.8M5781%N/A
#2
$105.1M5804%N/A
#3
$145.8M5817%N/A
#4
$104.9M5903%$29.5M
#5
$209.3M6208%N/A